Latest Biotech Startup Funding Rounds
Financing for drug discovery, therapeutics and biological technologies, with the development context behind each round.
- Rounds
- 477 Jan 1 – Oct 25, 2026
- Disclosed funding
- $20.2B 403 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| I ImperagenCompany profile Uses quantum physics simulation and AI to engineer high-performance enzymes for pharma and industrial markets Uses quantum physics simulation and AI to engineer high-performance enzymes for pharma and industrial markets | £5M | Seed | Biotech | United Kingdom | Investors | |
| E EfferonCompany profile Develops hemoadsorption therapeutic devices for sepsis and septic shock treatment Develops hemoadsorption therapeutic devices for sepsis and septic shock treatment | €2.5M | Seed | Biotech | Germany | Investors Undisclosed | |
| ER Engine RoomCompany profile Provides finance and accounting support to venture-backed life science companies Provides finance and accounting support to venture-backed life science companies | Undisclosed | StrategicUndisclosed | Biotech | United States | Investors | |
| Q QuberTechCompany profile Develops sustainable natural rubber from engineered dandelions using controlled-environment biotech Develops sustainable natural rubber from engineered dandelions using controlled-environment biotech | £3.4M | Seed | Biotech | United Kingdom | Investors | |
| BB Blank BioCompany profile Trains RNA foundation models on tumor transcriptomes to improve patient-level prediction in oncology Trains RNA foundation models on tumor transcriptomes to improve patient-level prediction in oncology | $7.2M | Seed | Biotech | United States | Investors | |
| FB Forlong BiotechnologyCompany profile Clinical-stage biotech developing cytokine therapies including IL-15 and IL-18 programs for cancer Clinical-stage biotech developing cytokine therapies including IL-15 and IL-18 programs for cancer | $17.5M | Pre-Series BUndisclosed | Biotech | China | Investors | |
| PB ProEncia BiotechnologyCompany profile Develops non-invasive periodontal care products for patients with periodontal disease Develops non-invasive periodontal care products for patients with periodontal disease | Undisclosed | Pre-SeedPre-seed | Biotech | United States | Investors Undisclosed | |
| CH Century HealthCompany profile Automates curation and enrichment of real-world clinical data for pharmaceutical and life sciences research Automates curation and enrichment of real-world clinical data for pharmaceutical and life sciences research | $5M | Seed | Biotech, Healthtech | United States | Investors | |
 Accro BioscienceCompany profile Clinical-stage medicines targeting inflammation and regulated cell-death pathways in immune-mediated disease. Clinical-stage medicines targeting inflammation and regulated cell-death pathways in immune-mediated disease. | $50M | Series CSeries C+ | Biotech | United States | Investors | |
| FT Full-Life TechnologiesCompany profile Clinical-stage radiotherapeutics company developing targeted cancer therapies with integrated isotope manufacturing Clinical-stage radiotherapeutics company developing targeted cancer therapies with integrated isotope manufacturing | $150M | Series D+DebtUndisclosed | Biotech | China | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1RA Capital Management
Estuary Biotherapeutics, Circle Pharma, Inc., Solstice Oncology
23rounds3led - 2Janus Henderson Investors
Star Therapeutics, OMass Therapeutics, Soufflé Therapeutics
15rounds1led - 3Eli Lilly and Company
BigHat Biosciences, Circle Pharma, Inc., Moonwalk Biosciences
15rounds0led - 4ARCH Venture Partners
Soufflé Therapeutics, Encoded Therapeutics Inc., Moonwalk Biosciences
14rounds0led - 5OrbiMed
Star Therapeutics, Leal Therapeutics, Accro Bioscience
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.